key: cord-0828991-05jlkamq authors: Eun, Lucy Youngmin title: Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children? date: 2021-03-05 journal: Clin Exp Pediatr DOI: 10.3345/cep.2021.00031 sha: e8f189eb3c3351282609f36674750a9b49c63157 doc_id: 828991 cord_uid: 05jlkamq nan 19 outbreak, patients newly diagnosed with KD demon strated a deterioration of biomarkers with evidence of immunocompromise and features of sepsis. This was an unusual form of KD or a form indicating possible KD-like MIS-C with shock. Although it is uncertain whether COVID-19 directly influences this change, it is important to pay careful attention because cases of MIS-C related to COVID-19 in children seem to be on the rise internationally. [3] [4] [5] [6] As most MIS-C cases were presented in Europe and the United States during the pandemic, rare reports are available of MIS-C in Korea, 7) implying that different genetic susceptibilities might play a role in the pathogenesis of MIS-C. As SARS-CoV-2 infects humans through the angiotensinconverting enzyme 2 (ACE2) receptor, the ACE2 receptor might be among the key factors responsible for vascular involvement in SARS-CoV-2 infection. The affinity of SARS-CoV-2 for the ACE2 receptor may render the vascular endothelial layer susceptible to attack. Patients present with an erythematous rash and vasculitis similar to the clinical manifestations of KD. [8] [9] [10] [11] Many factors have been associated with both altered ACE2 expression and COVID-19 severity and progression, including age, sex, ethnicity, medication, and several comorbidities such as cardiovascular disease and metabolic syndrome. 10, 11) In addition, most MIS-C patients were older than KD patients and presented with GI irritation. As previous research presented that coronavirus in the GI tract is associated with greater intestinal inflammation, the ACE2 receptor is a potential link between SARS-CoV-2 infection and intestinal inflammation. 12) Furthermore, Bunyavanich et al. 13) reported that ACE2 gene expression was lower in children and higher in adults. Moreover, in younger children, ACE2 expression might develop earlier in the GI tract than in the respiratory tract. Similarly, ACE2 is widely distributed in various human tissues, and many of its determinants have been well recognized; however, ACE2-expressing organs do not equally participate in COVID-19 pathophysiology, implying that other mechanisms are involved in coordinating cellular infection resulting in tissue damage. With the COVID-19 pandemic, it is important to consider why KD is prevalent in young children and its symptoms are similar to those of MIS-C in older children. It can be hypothesized that ACE2 expression may be related. This might be an answer to why COVID-19 occurs less frequently in children with lower ACE2 expression. All pediatricians should be aware of all KD-like symptoms or toxic shock syndrome, even in the absence of a confirmed diagnosis of COVID-19, and MIS-C should be considered during the COVID-19 pandemic to ensure proper treatment without the misdiagnosis or overdiagnosis of KD. Coronavirus infections in children including COVID-19 An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: an observational cohort study Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children -15 ECDC; 2020 Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease Hyperinflammatory shock in children during COVID-19 pandemic Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific brief Korean Society of Kawasaki Disease. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019 COVID-19, ACE2, and the cardiovascular consequences Coronavirus Disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection The ACE-2 in COVID-19: foe or friend? Structural basis for the recognition of the SARS-CoV-2 by full length human ACE-2 Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors Nasal gene expression of angiotensinconverting enzyme 2 in children and adults The authors report no potential conflicts of interest relevant to this article.See the article "Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019" via https://doi.org/10.3345/cep. 2020.01900.